Skip to content

KIWA BIO-TECH PRODUCTS GROUP CORP

company.status.inactive

CIK 1159275fmd_1W56NBEPDP2YQHHPTA4GCNY5TYManufacturing · Agricultural ChemicalsTemplate: Standard

Coverage: Jan 01, 2010 to Dec 31, 2019, 39 periods

Latest annual · FY2019

Millions
Total revenues
40
Gross profit
9
Operating income
(1)
Net income
(7)
Free cash flow
(2)

Latest quarter · Q4 FY2019

Millions
Total revenues
9
Gross profit
1
Operating income
(3)
Net income
(5)
Free cash flow
2
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2016 to FY2019
+60.9%
Revenue, 5 yearsFY2014 to FY2019
n/m
Net income, 5 yearsFY2014 to FY2019
n/m

KIWA BIO-TECH PRODUCTS GROUP CORP financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2019FY2018ChangeSource
Revenue$40.1 million$30.7 million+30.8%10-K 2020-05-29 · proof
Gross profit$9.3 million$8.3 million+13%10-K 2020-05-29 · proof
Operating income-$1.2 million$2.6 million-145.8%10-K 2020-05-29 · proof
Net income-$6.6 million$343,821-2,029.9%10-K 2020-05-29 · proof
Cash from operating activities$183,067-$1.6 million10-K 2020-05-29 · proof
Total assets$24.1 million$32.5 million-26%10-K 2020-05-29 · proof
Total liabilities$14.4 million$19.8 million-27.3%10-K 2020-05-29 · proof
Cash and cash equivalents$7,965$7,859+1.3%10-K 2020-05-29 · proof
What was KIWA BIO-TECH PRODUCTS GROUP CORP's revenue in fiscal 2019?
KIWA BIO-TECH PRODUCTS GROUP CORP reported revenue of $40.1 million for fiscal 2019 (the year ended Dec 31, 2019), against $30.7 million the year before (+30.8%). Source: the 10-K filed with the SEC on May 29, 2020. SEC
What was KIWA BIO-TECH PRODUCTS GROUP CORP's gross profit in fiscal 2019?
KIWA BIO-TECH PRODUCTS GROUP CORP reported gross profit of $9.3 million for fiscal 2019 (the year ended Dec 31, 2019), against $8.3 million the year before (+13%). Source: the 10-K filed with the SEC on May 29, 2020. SEC
What was KIWA BIO-TECH PRODUCTS GROUP CORP's operating income in fiscal 2019?
KIWA BIO-TECH PRODUCTS GROUP CORP reported operating income of -$1.2 million for fiscal 2019 (the year ended Dec 31, 2019), against $2.6 million the year before (-145.8%). Source: the 10-K filed with the SEC on May 29, 2020. SEC
What was KIWA BIO-TECH PRODUCTS GROUP CORP's net income in fiscal 2019?
KIWA BIO-TECH PRODUCTS GROUP CORP reported net income of -$6.6 million for fiscal 2019 (the year ended Dec 31, 2019), against $343,821 the year before (-2,029.9%). Source: the 10-K filed with the SEC on May 29, 2020. SEC
What was KIWA BIO-TECH PRODUCTS GROUP CORP's cash from operating activities in fiscal 2019?
KIWA BIO-TECH PRODUCTS GROUP CORP reported cash from operating activities of $183,067 for fiscal 2019 (the year ended Dec 31, 2019), against -$1.6 million the year before. Source: the 10-K filed with the SEC on May 29, 2020. SEC
What are KIWA BIO-TECH PRODUCTS GROUP CORP's total assets?
As of Dec 31, 2019, KIWA BIO-TECH PRODUCTS GROUP CORP reported total assets of $24.1 million, against $32.5 million a year earlier (-26%). Source: the 10-K filed with the SEC on May 29, 2020. SEC
What are KIWA BIO-TECH PRODUCTS GROUP CORP's total liabilities?
As of Dec 31, 2019, KIWA BIO-TECH PRODUCTS GROUP CORP reported total liabilities of $14.4 million, against $19.8 million a year earlier (-27.3%). Source: the 10-K filed with the SEC on May 29, 2020. SEC
What are KIWA BIO-TECH PRODUCTS GROUP CORP's cash and cash equivalents?
As of Dec 31, 2019, KIWA BIO-TECH PRODUCTS GROUP CORP reported cash and cash equivalents of $7,965, against $7,859 a year earlier (+1.3%). Source: the 10-K filed with the SEC on May 29, 2020. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1159275&period_type=annual&limit=5"

Information only, not investment advice.